Rosuvastatin Placebo, MK-0616 (Enlicitide chloride) Placebo, MK-0616, ROSUVASTATIN
MK-0616-037
Phase 3 small_molecule active
Quick answer
Rosuvastatin Placebo, MK-0616 (Enlicitide chloride) Placebo, MK-0616, ROSUVASTATIN for Hyperlipidemia is a Phase 3 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Hyperlipidemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active